|Description||Afimoxifene (4-hydroxytamoxifen) is a selective estrogen receptor modulator which is the active metabolite of tamoxifen. Afimoxifene is a transdermal gel formulation and is being developed by Ascend Therapeutics, Inc. under the trademark TamoGel. Afimoxifene has completed a phase II clinical trial for the treatment of cyclical mastalgia.|
|Synonyms||4-hydroxytamoxifene; 4-Hydroxytamoxifen ; Hydroxytamoxifen; Tamogel; 4-Hydroxy-tamoxifen ; para-Hydroxytamoxifen ; 4-Monohydroxytamoxifen ; trans-4-Hydroxytamoxifen; Tamoxifen metabolite B ; 4'-hydroxytamoxifen.|
|Current Developer||Ascend Therapeutics, Inc.|
BMS639623 is a CCR3 antagonist with picomolar inhibition potency against eosinophil chemotaxis. It may be used for the treatment of asthma.
A N-desmethyl analogue of the human PDE5 inhibitor Tadalafil. A potential antiplasmodial drug.
ARN 272 has been found to be a FLAT inhibitor and could show analgesic activities in CB1-mediated nociceptive and inflammatory pain.
Thalicarpine is a natural aporphine benzylisoquinoline vinca alkaloid with antineoplastic activity. Thalicarpine binds to and inhibits p-glycoprotein, the multi...
Risedronate Sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.
Tracazolate hydrochloride is a subtype-selective GABAA receptor modulator that potentiates or inhibits recombinant GABAA function depending on subunit combinati...
(24S)-24,25-Dihydroxycholecalciferol is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs.
Edaravone is a novel potent free radical scavenger that reduces reactive oxygen species, inhibites apoptosis, and blocks nonenzymatic peroxidation and lipoxygen...